These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21958313)

  • 1. Prescription rates of ADHD medication in the Scandinavian countries and their national guidelines.
    Bilenberg N; Gillberg C; Houmann T; Kadesjø B; Lensing MB; Plessen KJ; Strand G; Thomsen PH; Worning A
    Nord J Psychiatry; 2012 Feb; 66(1):70-1. PubMed ID: 21958313
    [No Abstract]   [Full Text] [Related]  

  • 2. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder.
    Vitiello B
    CMAJ; 2001 Nov; 165(11):1505-6. PubMed ID: 11762576
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and treatment characteristics of children with attention-deficit/hyperactivity disorder in psychiatric practice.
    Zarin DA; Suarez AP; Pincus HA; Kupersanin E; Zito JM
    J Am Acad Child Adolesc Psychiatry; 1998 Dec; 37(12):1262-70. PubMed ID: 9847498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
    Kalb C
    Newsweek; 2000 Mar; 135(10):53. PubMed ID: 10847892
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R; Hodgkins P; Meijer W
    Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ADHD drugs in the Nordic countries: a population-based comparison study.
    Zoëga H; Furu K; Halldórsson M; Thomsen PH; Sourander A; Martikainen JE
    Acta Psychiatr Scand; 2011 May; 123(5):360-7. PubMed ID: 20860726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary care providers often first line of ADHD treatment.
    Mitchell L
    J Okla State Med Assoc; 2009 Nov; 102(11):362. PubMed ID: 20034251
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.
    Gumy C; Huissoud T; Dubois-Arber F
    J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovations and recent trends in the treatment of ADHD.
    Madaan V; Kinnan S; Daughton J; Kratochvil CJ
    Expert Rev Neurother; 2006 Sep; 6(9):1375-85. PubMed ID: 17009924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2005 MSMS physician data survey on practice characteristics.
    Novak J
    Mich Med; 2005; 104(3):8-12, 14-6. PubMed ID: 15898274
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey.
    Owens JA; Rosen CL; Mindell JA; Kirchner HL
    Sleep Med; 2010 Aug; 11(7):692-700. PubMed ID: 20621556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the translation of an instrument to measure reliability of written information on treatment choices: a study on attention deficit/hyperactivity disorder (ADHD).
    Montoya A; Llopis N; Gilaberte I
    Educ Health (Abingdon); 2011 Dec; 24(3):577. PubMed ID: 22267353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the American Heart Association scientific statement on screening electrocardiograms and stimulant medications.
    Thomas PE; Carlo WF; Decker JA; Cannon BC; Kertesz NJ; Friedman RA; Kim JJ
    Arch Pediatr Adolesc Med; 2011 Feb; 165(2):166-70. PubMed ID: 21300657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which physician and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders?
    Smolders M; Laurant M; Verhaak P; Prins M; van Marwijk H; Penninx B; Wensing M; Grol R
    Med Care; 2010 Mar; 48(3):240-8. PubMed ID: 20125045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in medications administered in schools.
    McCarthy AM; Kelly MW; Johnson S; Roman J; Zimmerman MB
    J Sch Nurs; 2006 Apr; 22(2):102-7. PubMed ID: 16563033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (Against).
    Efron D
    J Paediatr Child Health; 2006 Sep; 42(9):548-51. PubMed ID: 16925543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.